RxDoctor Payments DataLook up a doctor →

Rancie Hannah, MD

Family Medicine · Ashland, KYNPI 1275530008

Payments from drug & device makers

$14,983in general payments, 2019–2025

Across 1,083 payments — averaging $13.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • Lilly USA, LLC$1K
  • Pfizer$1K
  • AstraZeneca$1K
  • Merck$650
  • plus $6K from 50 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)223$2,412
Novo Nordisk167$2,097
Lilly USA, LLC105$1,493
Pfizer79$1,179
AstraZeneca55$1,130
Merck49$650
GSK35$585
Johnson & Johnson(2 entities)68$581
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC29$485
Kowa Pharmaceuticals America, Inc.23$282
Teva Pharmaceuticals USA, Inc.15$265
Astellas Pharma US Inc13$262
Shield Therapeutics Inc6$248
Mylan Specialty L.p.8$212
Boehringer Ingelheim15$208
Sanofi-aventis U.S. LLC12$187
Axsome Therapeutics, Inc.8$185
Amarin Pharma, Inc.13$169
Amgen10$163
Aimmune Therapeutics, Inc.10$159
Biohaven Pharmaceutical Holding Company Ltd.20$151
Esperion Therapeutics, Inc.8$144
Abbott8$141
Biohaven Pharmaceuticals, Inc.15$139
Dexcom, Inc.8$137
Otsuka America Pharmaceutical, Inc.6$126
Novartis7$107
Bayer7$104
Corcept Therapeutics6$97
Xeris Pharmaceuticals, Inc.5$92
Exact Sciences5$87
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$73
Phathom Pharmaceuticals, Inc.3$59
Takeda Pharmaceuticals U.S.A., Inc.3$46
IBSA Pharma Inc.3$46
Arbor Pharmaceuticals, Inc.4$46
E.r. Squibb & Sons, L.L.C.3$45
Nestle Healthcare Nutrition Inc.3$39
Lundbeck LLC2$35
Sumitomo Pharma America, Inc.2$31
Shire North American Group Inc2$24
Sunovion Pharmaceuticals Inc.2$24
Seqirus USA Inc1$21
Tris Pharma Inc1$21
Alnylam Pharmaceuticals Inc.1$21
Abiomed1$21
Optos, Inc.1$19
Ultragenyx Pharmaceutical Inc.1$18
Daiichi Sankyo Inc.1$16
Supernus Pharmaceuticals, Inc.1$16
Assertio Therapeutics, Inc.1$15
Currax Pharmaceuticals LLC1$15
Organogenesis Inc.1$15
Eisai Inc.1$13
Ironwood Pharmaceuticals, Inc1$12
Redhill Biopharma Inc.1$11

How this compares

$14,983 in reported general payments places this provider in the 95th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$149,427
Medicare patients
362
Services billed
1,756

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Ashland

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →